{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T23:43:55Z","timestamp":1771371835324,"version":"3.50.1"},"reference-count":58,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"unspecified","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2023,8,7]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>Percutaneous coronary intervention (PCI) is widely adopted to treat chronic coronary artery disease. Numerous randomised trials have been conducted to test whether PCI may provide any prognostic advantage over oral medical therapy (OMT) alone, without definitive results. This has maintained the paradigm of OMT as the first-line standard of care for patients, reserving PCI for symptom control. In this review, we discuss the current evidence in favour and against PCI in stable coronary syndromes and highlight the pitfalls of the available studies. We offer a critical appraisal of the possible reasons why the existing data does not provide evidence supporting the role of PCI in improving clinical outcomes in patients with stable coronary syndromes.<\/jats:p>","DOI":"10.1136\/openhrt-2023-002343","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T09:30:28Z","timestamp":1698399028000},"page":"e002343","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Why percutaneous revascularisation might not reduce the risk of myocardial infarction and mortality in patients with stable CAD?"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9669-4278","authenticated-orcid":false,"given":"Stefano","family":"Benenati","sequence":"first","affiliation":[{"name":"Cardiovascular Disease Chair, Department of Internal Medicine (Di.M.I.), University of Genova, Genova, Italy"},{"name":"Oxford Heart Centre, John Radcliffe Hospital, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Luigi","family":"De Maria","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, John Radcliffe Hospital, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafail","family":"Kotronias","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, John Radcliffe Hospital, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Italo","family":"Porto","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Chair, Department of Internal Medicine (Di.M.I.), University of Genova, Genova, Italy"},{"name":"Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, IRCCS, Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian P","family":"Banning","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, John Radcliffe Hospital, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"2025081711064112000_10.2.e002343.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.078"},{"key":"2025081711064112000_10.2.e002343.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070829"},{"key":"2025081711064112000_10.2.e002343.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805796"},{"key":"2025081711064112000_10.2.e002343.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205361"},{"key":"2025081711064112000_10.2.e002343.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915922"},{"key":"2025081711064112000_10.2.e002343.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.062714"},{"key":"2025081711064112000_10.2.e002343.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.048194"},{"key":"2025081711064112000_10.2.e002343.8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.carrev.2021.12.005","article-title":"Revascularization or optimal medical therapy for stable ischemic heart disease: a Bayesian meta-analysis of contemporary trials","volume":"40","author":"Kumar","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"2025081711064112000_10.2.e002343.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab246"},{"key":"2025081711064112000_10.2.e002343.10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019114","article-title":"Death and myocardial infarction following initial revascularization versus optimal medical therapy in chronic coronary syndromes with myocardial ischemia: a systematic review and meta-analysis of contemporary randomized controlled trials","volume":"10","author":"Soares","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2025081711064112000_10.2.e002343.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2022.10.023"},{"key":"2025081711064112000_10.2.e002343.12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.23736\/S2724-5683.21.05645-3","article-title":"Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural Infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials","volume":"71","author":"Galli","year":"2023","journal-title":"Minerva Cardiol Angiol"},{"key":"2025081711064112000_10.2.e002343.13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab330"},{"key":"2025081711064112000_10.2.e002343.14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa2112299","article-title":"Fractional flow reserve-guided PCI as compared with coronary bypass surgery","volume":"386","author":"Fearon","year":"2022","journal-title":"N Engl J Med"},{"key":"2025081711064112000_10.2.e002343.15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"2025081711064112000_10.2.e002343.16","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000072790.23090.41"},{"key":"2025081711064112000_10.2.e002343.17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1586\/14779072.2014.874285","article-title":"Is myocardial ischemia really bad for you?","volume":"12","author":"Dweck","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2025081711064112000_10.2.e002343.18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.743963"},{"key":"2025081711064112000_10.2.e002343.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.02.014"},{"key":"2025081711064112000_10.2.e002343.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.049755"},{"key":"2025081711064112000_10.2.e002343.21","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.jcin.2022.08.024","article-title":"Impact of nonobstructive left main coronary artery atherosclerosis on long-term mortality","volume":"15","author":"Noguchi","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2025081711064112000_10.2.e002343.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002358"},{"key":"2025081711064112000_10.2.e002343.23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/eurheartj\/ehz520","article-title":"Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study","volume":"41","author":"Prati","year":"2020","journal-title":"Eur Heart J"},{"key":"2025081711064112000_10.2.e002343.24","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.2022.5218","article-title":"Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial","volume":"327","author":"R\u00e4ber","year":"2022","journal-title":"JAMA"},{"key":"2025081711064112000_10.2.e002343.25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.120.046289","article-title":"Ten-year all-cause death according to completeness of revascularization in patients with three-vessel disease or left main coronary artery disease: insights from the SYNTAX extended survival study","volume":"144","author":"Takahashi","year":"2021","journal-title":"Circulation"},{"key":"2025081711064112000_10.2.e002343.26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.120.045007","article-title":"ISCHEMIA trial: was it worth the wait?","volume":"142","author":"Al-Lamee","year":"2020","journal-title":"Circulation"},{"key":"2025081711064112000_10.2.e002343.27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jchf.2021.02.015","article-title":"Lessons from the ISCHEMIA trial for preventing collateral damage on clinical trial outcomes","volume":"9","author":"Thomas","year":"2021","journal-title":"JACC Heart Fail"},{"key":"2025081711064112000_10.2.e002343.28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jtcvs.2020.08.010","article-title":"Commentary: the ISCHEMIA trial: throwing the baby out with the Bathwater?","volume":"162","author":"Grimm","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025081711064112000_10.2.e002343.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.016"},{"key":"2025081711064112000_10.2.e002343.30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047987"},{"key":"2025081711064112000_10.2.e002343.31","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/eurheartj\/ehx799","article-title":"Periprocedural myocardial infarction and injury in elective coronary stenting","volume":"39","author":"Zeitouni","year":"2018","journal-title":"Eur Heart J"},{"key":"2025081711064112000_10.2.e002343.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.08.059"},{"key":"2025081711064112000_10.2.e002343.33","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4244\/EIJY19M01_01","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"14","author":"Neumann","year":"2019","journal-title":"EuroIntervention"},{"key":"2025081711064112000_10.2.e002343.34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.carrev.2018.01.005","article-title":"Invasive \"in the Cath-lab\" assessment of myocardial ischemia in patients with coronary artery disease: when does the gold standard not apply?","volume":"19","author":"Benenati","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"key":"2025081711064112000_10.2.e002343.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.060"},{"key":"2025081711064112000_10.2.e002343.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.06.020"},{"key":"2025081711064112000_10.2.e002343.37","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.jcin.2022.07.015","article-title":"Functional patterns of coronary disease: diffuse, focal, and serial lesions","volume":"15","author":"Scarsini","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2025081711064112000_10.2.e002343.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.07.072"},{"key":"2025081711064112000_10.2.e002343.39","doi-asserted-by":"crossref","unstructured":"Collet C , Collison D , Mizukami T , et al . n.d. Differential improvement in angina and health-related quality of life after percutaneous coronary interventions in focal and diffuse coronary artery disease. JACC Cardiovasc Interv 2022 Dec 26;15(24):2506-2518 doi:10.1016\/j.jcin.2022.09.048","DOI":"10.1016\/j.jcin.2022.09.048"},{"key":"2025081711064112000_10.2.e002343.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1616540"},{"key":"2025081711064112000_10.2.e002343.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.01.087"},{"key":"2025081711064112000_10.2.e002343.42","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2013.86"},{"key":"2025081711064112000_10.2.e002343.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.07.973"},{"key":"2025081711064112000_10.2.e002343.44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.carrev.2019.05.018","article-title":"Optimal treatment strategy for coronary artery stenoses with grey zone fractional flow reserve values. A systematic review and meta-analysis","volume":"21","author":"Andreou","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"2025081711064112000_10.2.e002343.45","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-316075"},{"key":"2025081711064112000_10.2.e002343.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2012.10.014"},{"key":"2025081711064112000_10.2.e002343.47","first-page":"1077","article-title":"Factors associated with deferred lesion failure following fractional flow reserve assessment in patients with diabetes mellitus","volume":"90","author":"Kennedy","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025081711064112000_10.2.e002343.48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2016.05.032","article-title":"Relation between fractional flow reserve value of coronary lesions with deferred revascularization and cardiovascular outcomes in non-diabetic and diabetic patients","volume":"219","author":"Liu","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025081711064112000_10.2.e002343.49","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab433"},{"key":"2025081711064112000_10.2.e002343.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA1907775\/SUPPL_FILE\/NEJMOA1907775_DATA-SHARING.PDF"},{"key":"2025081711064112000_10.2.e002343.51","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008768","article-title":"Nonculprit lesion plaque morphology in patients with ST-segment-elevation myocardial infarction: results from the COMPLETE trial optical coherence tomography Substudys","volume":"13","author":"Pinilla-Echeverri","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2025081711064112000_10.2.e002343.52","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2104650"},{"key":"2025081711064112000_10.2.e002343.53","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011314","article-title":"Compared outcomes of ST-segment-elevation myocardial infarction patients with multivessel disease treated with primary percutaneous coronary intervention and preserved fractional flow reserve of nonculprit lesions treated conservatively and of those with low fractional flow reserve managed Invasively: insights from the FLOWER-MI trial","volume":"14","author":"Denormandie","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"2025081711064112000_10.2.e002343.54","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00249-x"},{"key":"2025081711064112000_10.2.e002343.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2015.12.023"},{"key":"2025081711064112000_10.2.e002343.56","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"2025081711064112000_10.2.e002343.57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jamacardio.2019.0275","article-title":"Coronary atherosclerotic phenotype and plaque healing in patients with recurrent acute coronary syndromes compared with patients with long-term clinical stability: an in vivo optical coherence tomography study","volume":"4","author":"Vergallo","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2025081711064112000_10.2.e002343.58","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/jamacardio.2022.3926","article-title":"Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease management-the plaque hypothesis: a narrative review","volume":"8","author":"Stone","year":"2023","journal-title":"JAMA Cardiol"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2023-002343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T18:06:54Z","timestamp":1755454014000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2023-002343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,10,27]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/openhrt-2023-002343"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2023-002343","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}